We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
Updated: 12/14/2016
An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients
Updated: 12/14/2016
A Randomized-Controlled Three-arm Phase II Study of Lurbinectedin (PM01183) Alone or In Combination With Gemcitabine and a Control Arm With Docetaxel as Second-Line Treatment in Unresectable Non-Small Cell Lung Cancer (NSCLC) Patients
Status: Enrolling
Updated: 12/14/2016
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients
Updated: 12/14/2016
A Randomized-Controlled Three-arm Phase II Study of Lurbinectedin (PM01183) Alone or In Combination With Gemcitabine and a Control Arm With Docetaxel as Second-Line Treatment in Unresectable Non-Small Cell Lung Cancer (NSCLC) Patients
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Updated: 12/14/2016
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials

Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Updated: 12/14/2016
CLINICAL AND PHARMACOLOGICAL STUDY OF CHEMOTHERAPY IN SOFT TISSUE SARCOMA
Status: Enrolling
Updated: 12/14/2016
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Updated: 12/14/2016
CLINICAL AND PHARMACOLOGICAL STUDY OF CHEMOTHERAPY IN SOFT TISSUE SARCOMA
Status: Enrolling
Updated: 12/14/2016
Click here to add this to my saved trials
